Kewaunee Scientific (NASDAQ:KEQU) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Kewaunee Scientific Co. (NASDAQ:KEQU)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $47.48 and traded as high as $66.04. Kewaunee Scientific shares last traded at $60.40, with a volume of 21,250 shares.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.

Kewaunee Scientific Trading Down 8.6 %

The company has a debt-to-equity ratio of 0.45, a current ratio of 2.64 and a quick ratio of 2.13. The company has a market cap of $173.35 million, a price-to-earnings ratio of 9.57 and a beta of 0.71. The business’s fifty day moving average price is $60.22 and its 200 day moving average price is $47.48.

Kewaunee Scientific (NASDAQ:KEQU) last announced its earnings results on Wednesday, December 11th. The technology company reported $1.41 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Insider Buying and Selling

In other news, CFO Donald T. Gardner III sold 1,257 shares of the business’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $59.26, for a total value of $74,489.82. Following the transaction, the chief financial officer now directly owns 21,358 shares of the company’s stock, valued at $1,265,675.08. The trade was a 5.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Elizabeth D. Phillips sold 1,850 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total value of $100,214.50. Following the sale, the vice president now owns 13,591 shares in the company, valued at approximately $736,224.47. The trade was a 11.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,994 shares of company stock valued at $729,430 over the last ninety days. 14.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Kewaunee Scientific

Several institutional investors have recently added to or reduced their stakes in the business. Bank of America Corp DE grew its position in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the period. JPMorgan Chase & Co. boosted its stake in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares in the last quarter. IFP Advisors Inc acquired a new stake in Kewaunee Scientific in the fourth quarter worth $36,000. Morgan Dempsey Capital Management LLC bought a new stake in Kewaunee Scientific in the fourth quarter valued at $106,000. Finally, Barclays PLC acquired a new position in shares of Kewaunee Scientific during the third quarter valued at about $121,000. 32.69% of the stock is owned by institutional investors and hedge funds.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.